Nataliya Uboha, MD, PhD, is a medical oncologist specializing in gastrointestinal oncology. She serves as Associate Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care at the University of Wisconsin School of Medicine and Public Health, and is Associate Director of Clinical Research in the Department of Medicine at UW–Madison and the UW Carbone Cancer Center. She also practices as a gastrointestinal medical oncologist at the UW Carbone Cancer Center and UW Health, with a clinical focus on gastrointestinal cancer care, advanced disease management, and access to novel therapeutics. Her research interests center on early-phase clinical trials and drug development, biomarker-driven precision oncology, and immunotherapy for solid tumors. Dr. Uboha is faculty leader of the Early Phase Oncology Therapeutics Program and CTD2 team at UW Carbone, co-director of the Wisconsin Oncology Network, and co-leader of the Basket Disease-Oriented Team. Her national leadership roles include Chair of the Upper Gastrointestinal Working Group for ECOG-ACRIN, Co-Chair of the National Cancer Institute Upper GI Taskforce, Co-Chair of the Big Ten Cancer Research Consortium GI Clinical Trial Working Group, service on NCCN and ASCO committees, and membership on the Board of Advisors for the Global Medical Knowledge Alliance. Dr. Uboha earned her MD and PhD in Molecular Neuroscience through the Yale University School of Medicine MD/PhD Training Program. She completed her residency in Internal Medicine at Yale New Haven Hospital, followed by fellowship training in Medical Hematology and Oncology at Smilow Cancer Hospital at Yale New Haven Hospital.
Associate Professor
Medical School
1999 – 2007
Residency
2007 – 2010
Fellowship
2010 – 2013